All over the world, September is dedicated to raising awareness on blood and childhood cancers. Leukemia is the most commonly diagnosed cancer among children and acute lymphoblastic leukemia is the most prevalent type of this cancer.
This is the opportunity to remind that Servier is committed to fighting leukemia and to supporting patients and their families.
WHAT IS ACUTE LYMPHOBLASTIC LEUKEMIA?
Acute Lymphoblastic Leukemia (ALL) is a rare hematologic malignancy representing 12% of leukemia and 80% of all cases of childhood leukemia. ALL is a type of blood cancer developing from immature white blood cells (lymphocytes) in the bone marrow. In patients with leukemia, a large number of immature lymphocytes develop rapidly, hindering the production of healthy blood cells. If left untreated, the outcome can be fatal in the following weeks or months.
DID YOU KNOW?
This past few years, the diagnosis and treatment of Acute Lymphoblastic Leukemia has significantly improved and the five-year event free survival rate is currently over 80% for children and 30 to 70% for adults.
This September, we support the causes of #ChildhoodCancerAwarenessMonth and #BloodCancerAwarenessMonth. In response to the growing need for #therapeutic solutions, we have made #oncology one of our top #priorities.
— Servier (@Servier) September 9, 2019